This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of California. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Jane Isquith: Innovator in Anticancer Research
Introduction
Jane Isquith is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of cancer research, particularly in developing innovative compositions and methods for treating cancer. With a total of 2 patents, her work focuses on inhibiting specific proteins associated with cancer progression.
Latest Patents
Jane Isquith's latest patents include groundbreaking compositions and methods for treating or ameliorating cancer. These inventions aim to inhibit the expression or activity of Mouse Double Minute 2 homolog (MDM2), an APOBEC3G (A3G) protein, and an ADAR1p150 protein. By increasing the presence of inhibitory molecules in cells, her methods target the expression of these proteins, which can lead to decreased cancer cell propagation, particularly in leukemia.
Career Highlights
Jane Isquith is affiliated with the University of California, where she conducts her research and develops her innovative solutions. Her work has garnered attention for its potential to significantly impact cancer treatment methodologies.
Collaborations
Some of her notable coworkers include Catriona Jamieson and Raymond Diep, who collaborate with her on various research projects aimed at advancing cancer therapies.
Conclusion
Jane Isquith's contributions to cancer research through her innovative patents highlight her role as a key inventor in the field. Her work continues to pave the way for new treatment options that could improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile